Individuals at UPMC Chautauqua could participate in a trial that results in finding a treatment for COVID-19. Derek Angus, M.D., professor and chair, Department of Critical Care Medicine at Pitt and UPMC, talked recently about UPMC’s efforts to lead an international clinical trial supported by artificial intelligence.

Before COVID-19 emerged, Dr. Angus and international collaborators had developed a platform, called REMAP-Community Acquired Pneumonia (REMAP-CAP) designed to find optimal treatments for severe pneumonia both in non-pandemic and pandemic settings. When COVID-19 began circulating, REMAP-CAP was adapted to incorporate additional treatment regimens specifically . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!